Successful Installation of ETH 1.2 GHz NMR System Enables Novel Research Capabilities in Solid-State NMR
July 22 2020 - 8:30AM
Business Wire
ETH Zürich Accepts Bruker 1.2 GHz NMR
Spectrometer
Bruker Corporation (Nasdaq: BRKR) today announced the successful
installation and customer acceptance of the Avance™ NEO 1.2 GHz NMR
system at the Department of Chemistry and Applied Biosciences of
the Eidgen�ssische Technische Hochschule (ETH) Zürich (www.ethz.ch)
in Switzerland. Following the acceptance of the world's first 1.2
GHz NMR at the CERM (www.cerm.unifi.it) of the University of
Florence earlier this year, this marks the second customer
installation of a 1.2 GHz NMR in the world.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20200722005168/en/
Bruker Avance™ NEO 1.2 GHz NMR system at
the Eidgen�ssische Technische Hochschule (ETH) Zürich (Photo:
Business Wire)
ETH will utilize their new 1.2 GHz NMR system to enable the
development of new solid-state NMR techniques, and to apply these
techniques to study materials and biological systems, including
proteins fibrils which are linked to diseases such as Parkinson’s
and Alzheimer’s. The 1.2 GHz spectrometer will also be used as a
basis for further improving NMR methodology towards in-cell
structural biology, and to investigate solid catalysts and
functional materials, e. g. for energy conversion and data
storage.
Professors Beat Meier, Matthias Ernst and Alexander Barnes at
ETH stated: “We are very excited to have the world’s first 1.2 GHz
solid-state NMR spectrometer successfully installed in our lab. The
system was delivered just a couple of months ago and the
installation and energizing of the NMR magnet went exceptionally
well. The completion of the installation marks the culmination of a
project that we started with Bruker almost a decade ago. We are
very much looking forward to starting our first ultra-high field
solid-state NMR experiments.”
Dr. Falko Busse, Bruker BioSpin's Group President, commented: "I
am very grateful for the confidence and the trust our partners at
ETH have placed in Bruker, and for the outstanding support they
gave to our engineers during the installation of the 1.2 GHz NMR.
The second successful customer installation of a 1.2 GHz NMR is a
testament to the success of our newly developed Ultra-High-Field
(UHF) NMR technology. The production of additional UHF systems is
well underway. In fact, the installation of the next 1.2 GHz
spectrometer will commence at the Max Planck Institute (MPI) in
G�ttingen, Germany this week. We are thrilled to be able to provide
the structural biology and NMR research community with such
powerful tools."
Bruker's unique 1.2 GHz NMR magnets utilize a novel hybrid
technology with advanced high-temperature superconductors (HTS) in
the inner sections, and low-temperature metallic superconductors
(LTS) in the outer sections. The Ascend™ 1.2 GHz magnets are
stable, homogenous, standard-bore (54 mm) magnets that meet the
requirements of high-resolution and solid-state NMR. Bruker's
Avance™ NEO 1.2 GHz spectrometers offer different ultra-high field
CryoProbes™ for solution-state NMR and fast-spinning MAS
solid-state probes.
About Bruker Corporation (Nasdaq: BRKR)
Bruker is enabling scientists to make breakthrough discoveries
and develop new applications that improve the quality of human
life. Bruker’s high-performance scientific instruments and
high-value analytical and diagnostic solutions enable scientists to
explore life and materials at molecular, cellular and microscopic
levels. In close cooperation with our customers, Bruker is enabling
innovation, improved productivity and customer success in life
science molecular research, in applied and pharma applications, in
microscopy and nanoanalysis, and in industrial applications, as
well as in cell biology, preclinical imaging, clinical phenomics
and proteomics research and clinical microbiology. For more
information, please visit: www.bruker.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200722005168/en/
Investor Contact: Investor Contact: Miroslava Minkova
Director, Investor Relations & Corporate Development T: +1
(978) 663-3660 x1479 E: Investor.Relations@bruker.com
Media Contact: Thorsten Thiel, Ph.D. VP of Group
Marketing Bruker BioSpin T: +49 (721) 5161–6500 E:
thorsten.thiel@bruker.com
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Aug 2024 to Sep 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Sep 2023 to Sep 2024